Cargando…

Serum Elafin as a Potential Marker of Disease Activity in Behçet's Disease

BACKGROUND: Elafin is a serine protease inhibitor with anti-inflammatory properties. It is expressed in various epithelial tissues with increased production under inflammatory conditions. Increased tissue elafin expression in Behçet's disease (BD) lesions has previously been demonstrated. AIMS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutlay, Armagan, Kose, Afet Akdag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564207/ https://www.ncbi.nlm.nih.gov/pubmed/37822392 http://dx.doi.org/10.4103/ijd.ijd_913_22

Ejemplares similares

Direct Immunofluorescence in Behçet's Disease: A Controlled Study with 108 Cases
por: Kose, Afet Akdag
Publicado: (2009)

The risk of endothelial and erectile dysfunctions in Behçet’s disease: a comparative analysis of mucocutaneous and systemic patient groups
por: Erdem, Yasemin, et al.
Publicado: (2021)

Clinical Significance of Serum Elafin in Children with Inflammatory Bowel Disease
por: Krawiec, Paulina, et al.
Publicado: (2022)

Elafin and its precursor trappin‐2: What is their therapeutic potential for intestinal diseases?
por: Deraison, Céline, et al.
Publicado: (2022)

Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease
por: Omma, Ahmet, et al.
Publicado: (2018)

Development of Immunopathogenesis Strategies to Treat Behçet's Disease
por: Köse, Osman
Publicado: (2012)

High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures
por: Wang, Jiani, et al.
Publicado: (2020)

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021)

Serum IL-17A in Behçet's disease
por: Emiroglu, Nazan, et al.
Publicado: (2015)

Clinical Significance of Serum Bilirubin in Behçet's Disease
por: Koca, Tuba Tülay
Publicado: (2018)

Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris
por: Holmannova, Drahomira, et al.
Publicado: (2020)

Elafin: a double agent in breast and ovarian cancer
por: Feng, Yi, et al.
Publicado: (2015)

High Expression and Clinical Significance of Elafin in Colorectal Cancer
por: Liu, Yun, et al.
Publicado: (2019)

Serum ghrelin levels in patients with Behcet’s disease
por: Erden, Ilker, et al.
Publicado: (2016)

Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
por: Xie, Ying, et al.
Publicado: (2022)

Serum Profiles of Cytokines in Behcet’s Disease
por: Sadeghi, Alireza, et al.
Publicado: (2017)

Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
por: Hunt, Kelly K, et al.
Publicado: (2013)

Plasma elafin, cathelicidin, and α-defensins are increased in paediatric inflammatory Crohn’s disease and reflect disease location
por: Wędrychowicz, Andrzej, et al.
Publicado: (2021)

Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus.
por: Yamamoto, S., et al.
Publicado: (1997)

Serum PLR and LMR in Behçet's disease: Can they show the disease activity?
por: Jiang, Ying, et al.
Publicado: (2017)

Behçet's Disease (Adamantiades-Behçet's Disease)
por: Kaneko, Fumio, et al.
Publicado: (2011)

Effects of breast milk on Behçet’s disease clinical features
por: KONAK, Hatice Ecem, et al.
Publicado: (2023)

Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
por: Kim, Dae-Jun, et al.
Publicado: (2013)

Potential Infectious Etiology of Behçet's Disease
por: Galeone, Massimiliano, et al.
Publicado: (2012)

Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells
por: Jasinghe, Viraj J., et al.
Publicado: (2013)

The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study
por: Baykal, Can, et al.
Publicado: (2019)

Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2
por: Yin, Lei, et al.
Publicado: (2010)

Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency
por: Sweatt, Andrew J., et al.
Publicado: (2021)

Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease
por: Hirohata, Shunsei, et al.
Publicado: (2020)

Elafin as a Prognostic Marker in Esophageal Squamous Cell Carcinoma: A Pilot Study Using Three-Dimensional Imaging and Genomic Profiling
por: Chen, Wei-Chung, et al.
Publicado: (2023)

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
por: Lu, Weiyu, et al.
Publicado: (2023)

Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach
por: ARMAĞAN, Berkan, et al.
Publicado: (2023)

Behçet's disease
por: Hirohata, Shunsei, et al.
Publicado: (2003)

Behçet's disease
por: Saadoun, David, et al.
Publicado: (2012)

Behçet Disease
por: Di Dier, Kelly, et al.
Publicado: (2022)

Activated protein C resistance in Behcet’s disease
por: Abdel Badaee, Hoda, et al.
Publicado: (2013)

Macular hole in Behçet's disease
por: Al-Dhibi, Hassan, et al.
Publicado: (2011)

Behcet's Disease: Pakistani Experience
por: Khan, Asadullah, et al.
Publicado: (2020)

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2014)

IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections
por: Kheir, Saadé, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nabas0t2pnqrpdlckth5mcfkc2